Abstract. Aquaporins (AQPs) are important in controlling bile formation, however, the exact role of AQPs in human biliary tract carcinogenesis has not been clearly defined. In this study, we analyzed AQP-1, -4, -5 and -8 expression immunohistochemically using tissue microarrays (TMAs) in 81 samples. (45 gallbladder carcinomas and 36 bile duct carcinomas). The survival of patients with high AQP-5 expression was longer compared to that of patients with low AQP-5 expression (P=0.017). Cox's proportional hazard model revealed that AQP-5 expression was an independent prognostic factor (RR, 0.38; P=0.025). Chi-square analysis revealed that high AQP-5 expression correlated to small tumor size in biliary tract carcinoma patients (P=0.006). With regard to the expression of other AQPs, depth of tumor invasion, histological type and serum carbohydrate antigen 19-9 (CA19-9) were associated with high AQP-1 expression (P=0.039, 0.011 and 0.032). However, AQP-4 and AQP-8 expression had no association with clinicopathological factors. Among the 10 patients who underwent gemcitabine (GEM) plus S-1 postoperative chemotherapy, the group of patients (n=5) with high AQP-5 expression were associated with higher rates of both overall and disease-free survival (log-rank P=0.033, 0.002). In conclusion, the results of this study suggest that AQP-5 expression may be associated with prognosis and drug sensitivity in biliary tract carcinoma.
Introduction
Aquaporins (AQPs) are integral membrane proteins which facilitate the movement of water, and they are expressed in many kinds of cells, especially in polarized epithelial cells (1) (2) (3) . AQPs are essential for bile water secretion and reabsorption. However, little is known about the function of AQPs water channels in human biliary tract carcinoma. At least 3 AQPs, AQP-1, -4 and -8, are known to be expressed in the biliary tract (4) . AQP-1 and -4 are also implicated in the intrahepatic bile duct absorption of water (5) . The epithelial cells of human and mouse gallbladder express AQP-1 and -8 (6, 7) . In the human gallbladder, AQP-1 is localized on both the apical and basolateral plasma membranes of epithelial cells lining the neck portion of the organ (6) .
Recently, it seems that AQP has an important role in human carcinogenesis. We previously reported that AQP-5 may be involved in differentiation of human gastric carcinoma cells, and overexpression of several aquaporins has been reported in different types of human carcinoma (8) (9) (10) (11) (12) (13) (14) (15) (16) . However, the role of AQPs in biliary tract carcinogenesis has not yet been clearly defined. Biliary tract carcinoma, consisting of gallbladder carcinoma and bile duct carcinoma, is a more lethal disease compared to other gastrointestinal cancers. The resection rate and the curative resection rate were 67.0-69.8% and 30.4-37.7%, respectively (17) . The five-year survival rate after surgical resection was 41.6% for gallbladder carcinoma, and 33.1% for bile duct carcinoma (17) . Surgical resection is the only chance for a cure, however, it is only applicable for selected patients. Thus, in order to understand the mechanisms in biliary tract carcinoma, we evaluated the role of AQPs on biliary tract carcinoma.
Materials and methods
Tissue samples. A series of surgical specimens from patients with biliary tract carcinoma were used. The patients with distant metastasis were excluded from the analysis. We used paraffin-embedded tissues of 81 samples (45 gallbladder carcinoma, 36 bile duct carcinoma) of the patients who underwent surgery from 1997 to 2010 at Toyama University Hospital, Japan. All samples were histologically diagnosed at the Department of Pathology. Immunohistochemical staining. AQP-1, -4, -5 and -8 expression were analyzed by TMAs (Fig. 1A) . The protein expressions of the AQPs were evaluated by the combination of the immunohistological intensity and distribution (18) . The plot underwent a primary analysis and a secondary analysis. The average score were used for further study. The final decision was made by discussion of two researchers (S.S. and R.H.). Images of immunohistochemistry staining were photographed under a microscope, and digitized slide images were analyzed ( ) antibodies were used at 1:50 dilution. The secondary antibodies used were goat anti-rabbit IgG-HRP according to the manufacturer's instructions. The staining intensity was scored as: 0, no staining of carcinoma cells; 1, weak staining; 2, moderate staining; 3, marked staining. The staining distribution within the tumor cells was graded as: 0, <10%; 1, ≥10% -<50%; and 2, ≥50%). Expression of AQPs in the carcinoma tissue was defined as positive when the sum total of the staining intensity and distribution was 3 or more ( Fig. 1C) . Polarization pattern were classified into two groups with polarized/mixed pattern or lost polarization pattern (Fig. 1D ).
Postoperative chemotherapy. There were 17 patients who underwent postoperative chemotherapy after aggressive surgical resection. There were 11 cases of R0 (microscopically margin-negative resection specimen with no residual microscopic or macroscopic tumor in the resection bed) and 6 cases of R1 (macroscopic tumor clearance but microscopically, margins were positive for tumor). As first-line chemotherapy, 7 patients received fluoropyrimidine (S-1) or fluorouracil chemotherapy, and 10 cases received gemcitabine (GEM) plus fluoropyrimidine (S-1) chemotherapy (GS). We analyzed the relationship between AQP expression and prognosis of the 10 patients who received GS treatment (19) (20) (21) .
Statistical analysis. The statistical evaluation was done by Chi-square test and t-test. Prognostic factors were examined by both univariate and multivariate analyses. Survival curves were estimated using the Kaplan-Meier method, and differences between survival curves were analyzed using the log-rank test. Multivariate analyses were produced using the Cox's proportional hazards model to test the risk of cancer death. The Chi-square model was used for analysis of the factors relating to AQP. All statistical analyses were considered significant 
Results
The expression of AQP-1, -4, -5 and -8 protein in biliary tract carcinoma tissues. The clinicopathological backgrounds of the patients are shown in Table Ⅰ . Table Ⅱ shows the AQP expression positivity in the bile duct and gallbladder carcinoma tissue. AQP-4 and -8 were more highly expressed in gallbladder carcinoma than in bile duct carcinoma. AQP-1 and -5 expression ratio was similar in the case of the two organs. Of the two, AQP-5 had the higher positivity. In the 49 high AQP-5 expression cases, loss of the subcellular polarization pattern was detected in 29 cases (Fig. 1D) . The rate of AQP-1 was 22/36, AQP-4 was 7/13, and all the 14 high AQP-8 expression were loss of polarization pattern.
Prognostic impact of AQP expression. Depth of tumor invasion, lymph node metastasis, TMN stage, tumor size (≥2.0), histological type, vascular invasion, carcinoembryonic antigen (CEA) (≥5), and CA19-9 (≥37) were associated with survival (P<0.001, 0.006, <0.001, 0.035, 0.002, 0.001, <0.001 and 0.019, respectively) ( Table Ⅲ) . Survival of the patients with high AQP-5 expression was significantly longer than that of the patients in the low AQP-5 expression group (P=0.017).
Other AQPs, AQP-1, -4 and -8 had no significant impact on survival (Fig. 2) . Furthermore, Cox's proportional hazard model revealed that AQP-5 expression was an independent prognostic factor (RR, 0.34; P=0.012). Depth of tumor invasion (Table Ⅲ) .
Analysis between AQP-1 and -5 expression and various prognostic factors.
We found that depth of tumor invasion and histological type were associated with AQP-1 expression (P=0.021 and 0.014). AQP-5 expression was significantly associated with tumor size (P=0.006) by Chi-square analysis.
No other relationship was observed between the clinicopathological characteristics of the patients and AQP-5 expression (Table Ⅳ) . There was no relationship between high AQP-1 expression and high AQP-5 expression (P=0.178) (data not shown). Multivariate logistic models revealed that there were no significant predictors for AQP-1 and -5 expression.
Relationship between the AQP-5 expression and the response to postoperative chemotherapy. As first-line chemotherapy, 7 patients received fluoropyrimidine (S-1) or fluorouracil chemotherapy, and 10 cases received gemcitabine (GEM) plus fluoropyrimidine (S-1) chemotherapy (GS). Table Ⅴ shows prognosis of biliary tract carcinoma patients who received GEM plus S-1 postoperative chemotherapy. Patients with high AQP-5 expression had significantly more favorable rate of both (Fig. 3A) overall and (Fig. 3B ) disease-free survival compared to patients with low AQP-5 expression (Fig. 3) (logrank test; P=0.033 and 0.002).
Discussion
The results of the study show that AQP-5 had the most important role in prognosis of biliary tract carcinoma among AQP-1, -4, -5 and -8. The multivariate proportional hazards model revealed that high AQP-5 expression was an independent and favorable prognostic factor. The results of this study differ from previous studies in colorectal and non-small cell lung cancers (12, 22) . AQP-5 induced cell proliferation via Ras/ERK/Rb pathway in colorectal cancer (22, 23) , and it promoted tumor invasion in nonsmall cell lung cancer (12) . Overexpression of AQP-5 increased proliferation and migration in colorectal and non-small cell lung carcinoma. The results of this study suggested that AQP-5 may play a different role in biliary tract carcinoma, such as facilitation of bile transport and reabsorption. The roles of biliary epithelium were different from those of the colon and of the lung (24) . With regard to the AQP-5 protein distribution (25) (26) (27) (28) (29) , the expression of AQP-5 in human ovarian tissues was reported to be mainly localized in the basolateral membrane of benign Table Ⅳ . Relationship between patient characteristics and AQP-1 and AQP-5 in biliary tract carcinoma. tumor cells and apical and basolateral membranes of borderline cells, or scattered in the membrane of malignant cells, and absent in the normal epithelium (30) . The results of our study were consistant with this report and AQP-5 expression was mixed or lost polarization and scattered in the membrane in more than half of the patients. AQP-1, -4 and -8 also show similar features. The expression of AQP-5 was associated with small tumor size in biliary tract cancer. This phenomenon was also observed in colon carcinoma (9, 16) . However, AQP expression was maintained through the late stage of colon carcinoma. These results suggested that AQP-5 was included in early-stage disease and might represent a functional ability of bile transfer channel in biliary tract carcinoma. Not only AQP-5 but also AQP-1 expression were correlated with clinicopathological factors. Similar AQP-1 and -5 expression patterns were observed in pancreatic carcinoma (31) . Furthermore, negative AQP-1 expression was an independent prognostic factor in intrahepatic cholangiocarcinoma (32) . Thus, AQP-1 also have some role in hepatobiliary and pancreatic carcinoma.
Univariate analysis Multivariate analysis ----------------------------------------------------------------------------------------------------------------------------------------------------
With regard to chemotherapy for biliary tract carcinoma, gemcitabine (GEM) and S-1 are commonly used. Although our study size was small, high AQP-5 expression showed an inverse association (P=0.011) with postoperative recurrence. The data suggested that expression of AQP-5 may play an important role in drug sensitivity. AQPs may be attractive targets for the development of novel drug therapies for disorders that involve aberrant water movement (33) (34) (35) (36) . However discovery of additional roles of AQPs is necessary.
In conclusion, this study shows that AQP-5 is highly expressed in biliary tract carcinoma. High AQP-5 expression was associated with small tumor size and favorable prognosis of biliary tract carcinoma patients. Our result suggest that AQPs expression demonstrates prognosis and drug sensitivity in biliary tract carcinoma. Further study of AQPs would contribute to the clinically treatment for biliary tract cancer. 
